Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Change in Accured Expenses (2016 - 2025)

Arrowhead Pharmaceuticals' Change in Accured Expenses history spans 16 years, with the latest figure at -$13.5 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 75.54% year-over-year to -$13.5 million; the TTM value through Dec 2025 reached $35.7 million, up 48.58%, while the annual FY2025 figure was $41.5 million, 29.21% up from the prior year.
  • Change in Accured Expenses reached -$13.5 million in Q4 2025 per ARWR's latest filing, down from $33.5 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $33.5 million in Q3 2025 to a low of -$20.1 million in Q1 2023.
  • Average Change in Accured Expenses over 5 years is $3.2 million, with a median of -$5500.0 recorded in 2023.
  • Peak YoY movement for Change in Accured Expenses: plummeted 1985.05% in 2024, then skyrocketed 6451.31% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at -$2.3 million in 2021, then tumbled by 214.54% to -$7.2 million in 2022, then surged by 105.66% to $408000.0 in 2023, then tumbled by 1985.05% to -$7.7 million in 2024, then crashed by 75.54% to -$13.5 million in 2025.
  • Per Business Quant, the three most recent readings for ARWR's Change in Accured Expenses are -$13.5 million (Q4 2025), $33.5 million (Q3 2025), and -$11.0 million (Q2 2025).